Every industry has its own communications specifics, and the pharmaceutical sector is no exception. Some of its requirements may not be obvious at first, while others come down to responsibility, ethics, and a clear understanding of the ultimate purpose behind any project.
Drawing on the experience working with clients in the pharmaceutical sector, the Newsfront team has put together a few practical tips to keep in mind when communicating for pharma brands.
Treat regulatory restrictions as part of your communications strategy
Pharmaceutical communications are subject to a range of legal and ethical restrictions, and the requirements vary depending on the product, audience, and channel. This means that in pharma, not everything that may seem like a good idea from a PR or marketing perspective can actually be used as a conventional communications tool.
At the same time, reviewing language and approving materials is not simply a formality — it is an integral part of the content creation process. This needs to be factored in from the very beginning, when developing ideas and planning topics, formats, and timelines.
We recommend focusing on education and awareness rather than the promotion of a specific therapy. Look for the intersection between topics that can be communicated within regulatory requirements, the interests of your audience, and the brand’s objectives.
Expertise matters more than making noise
Health is an area where exaggeration or oversimplification can do more than damage a brand’s reputation — it can also mislead the audience. That is why strong pharmaceutical communications should be grounded in evidence, accuracy, and the ability to explain complex topics in a clear and accessible way.
For communications teams, this means working closely with experts, research, primary sources, and investing significant effort in fact-checking.
Build more time into the approval process
In pharma, content often goes through a much longer approval process than in many other industries. Depending on the company’s structure, it may need to be reviewed by the communications team, medical experts, legal or compliance teams, and sometimes the global office.
This is why a newsroom deadline of “tomorrow” and the pharma approval process are not always the best match. A realistic timeline and a clear approval workflow help avoid situations where a news hook loses its relevance before the material is ready to go live.
The same applies to awareness months and disease-specific awareness days that are relevant to the client and aligned with their therapeutic areas and product portfolio.
Remember that a brand may have several very different audiences
Patients, physicians, pharmacists, professional communities, partners, media, and public institutions all have different levels of knowledge, different needs, different expectations of the company, and different ways of consuming information.
The same topic may therefore require different messages, arguments, and formats depending on the audience. This makes audience segmentation one of the foundations of effective pharmaceutical communications.
Think beyond individual campaigns
Pharma communications are about much more than talking about medicines. In this sector, reputation depends heavily on consistency. It is difficult to build trust through a single campaign or a handful of press releases.
Expert content, transparent communication, strong spokesperson management, a consistent presence in the professional information landscape, and the ability to address complex topics responsibly all contribute to trust over time.
Ultimately, effective pharma communications require a constant balance between engaging content, regulatory requirements, and responsibility towards the audience. The better this balance is embedded in the team’s processes, the more room there is for communications that are both creative and genuinely effective.
